Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
POLL Medical is a private U.S. medical device company focused on supportive devices used during radiation oncology procedures. Its principal product is the GrayDuck Stent, a custom-fitted oral stent designed to immobilize the jaw and displace the tongue during head and neck radiotherapy in order to spare healthy oral tissues and improve treatment reproducibility. The company markets the device as a patient-specific product that can be fitted quickly in clinic and has highlighted independent clinical studies supporting stability, tolerability, and mucosal sparing. FDA records indicate the GrayDuck Stent received 510(k) clearance in 2019. Overall, POLL Medical appears to be a small, commercially oriented radiation-oncology device company rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on POLL Medical.